<![CDATA[]]> <![CDATA[Cobra Biologics and Novolytics Unveil Successful Development of Bacteriophages Against Bacterial Infection ]]> Cobra Biologics Ltd, the International clinical and commercial manufacturer of biologics and pharmaceuticals and Novolytics, a biotechnology company developing anti-infective products, today announce a breakthrough in the development of two Staphylococcus aureus based phage products for Phase I clinical trials with a 100 fold increase in upstream process yields. ]]> Tue, 11 Jun 2013 00:00:00 GMT <![CDATA[Cobra and Recopharma Enter agreement to utilise Cobra’s Cell Line Development Service- MaxXpress]]> Cobra Biologics Ltd, the international clinical and commercial manufacturer of biologics and pharmaceuticals and Recopharma, a biotechnology company developing ophthalmic products, today announce an agreement to supply a human Fc fusion protein using Cobra’s maxXpress service.
]]> Tue, 28 May 2013 00:00:00 GMT <![CDATA[Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine]]> Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine]]> Tue, 14 May 2013 00:00:00 GMT <![CDATA[Cobra Biologics Wins Innovation Grant]]> Knowledge Transfer Partnership award granted between the University of Birmingham and Cobra Biologics]]> Tue, 26 Mar 2013 00:00:00 GMT <![CDATA[Cobra Biologics’ Growth Is Strengthened]]> A new non-executive director joins Cobra’s board to support expansion plans

]]> Tue, 23 Oct 2012 00:00:00 GMT <![CDATA[Cobra Biologics and Algeta Sign Agreement to Manufacture Monoclonal Antibody ]]> Cobra Biologics and Algeta Sign Agreement to Manufacture Monoclonal Antibody ]]> Tue, 04 Sep 2012 00:00:00 GMT <![CDATA[Cobra Biologics and KAHR Medical extend their partnership to develop both KAHR-101 and KAHR-102]]> Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals and KAHR Medical Limited, that develops novel drugs based on the Signal Converter Proteins (SCP) technology for the treatment of cancer and autoimmune diseases, announced today a continuation of their partnership.

]]> Tue, 26 Jun 2012 00:00:00 GMT <![CDATA[Cobra Biologics and Alligator Bioscience AB Sign Monoclonal Antibody Manufacturing Agreement ]]> Cobra Biologics and Alligator Bioscience AB Sign Monoclonal Antibody Manufacturing Agreement]]> Tue, 12 Jun 2012 00:00:00 GMT <![CDATA[Cobra Biologics Wins Manufacturing Agreement to Produce Anaerobic Bacteria]]> Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, today announces that it has signed an agreement with a clinical stage biotechnology company to produce a Drug Substance under cGMP.

]]> Wed, 29 Feb 2012 00:00:00 GMT <![CDATA[Cobra Biologics’ Expansion Continues]]> Three non-executive directors and two business development managers join to help expand the Company’s growing manufacturing business ]]> Mon, 13 Feb 2012 00:00:00 GMT <![CDATA[Cobra Biologics Acquires Unitech Pharma Group]]> Cobra Biologics acquires Unitech Pharma Group to expand its capacity and biopharmaceutical service offering. ]]> Mon, 31 Oct 2011 00:00:00 GMT <![CDATA[New Branding for a Fresh Corporate Identity]]> ]]> Mon, 03 Oct 2011 00:00:00 GMT <![CDATA[Appointmment of Commercial Director]]> ]]> Tue, 26 Jul 2011 00:00:00 GMT <![CDATA[Cobra Biologics Holding AB acquires Recipharm AB’s shares in RecipharmCobra Biologics]]> ]]> Thu, 30 Jun 2011 00:00:00 GMT <![CDATA[Continuation of Partnership in the Development of KAHR-102]]> ]]> Mon, 20 Jun 2011 00:00:00 GMT <![CDATA[Patents Granted on Bacterial Genetic Modification Technology (Xer-cise™)]]> ]]> Wed, 02 Feb 2011 00:00:00 GMT <![CDATA[Successful Pre-Clinical TB Vaccine Results using Oral Vaccine Delivery Platform (ORT-VAC™)]]> ]]> Thu, 13 Jan 2011 00:00:00 GMT <![CDATA[Approval for Research and Development Tax Credit (Le Crédit d’Impôt Recherche (CIR)) from the French Ministry for Higher Education and Research]]> Approval for Research and Development Tax Credit (Le Crédit d’Impôt Recherche (CIR)) from the French Ministry for Higher Education and Research]]> Tue, 02 Nov 2010 00:00:00 GMT <![CDATA[Patent for Novel Antibiotic-Free Plasmid Maintenance System]]> Patent for Novel Antibiotic-Free Plasmid Maintenance System]]> Tue, 31 Aug 2010 00:00:00 GMT <![CDATA[Recipharm Biologics and Cobra Biomanufacturing plc combine]]> ]]> Mon, 22 Feb 2010 00:00:00 GMT <![CDATA[Response to the Mandatory Cash Offer by Recipharm AB ("Recipharm")]]>
]]> Mon, 21 Dec 2009 00:00:00 GMT <![CDATA[Recipharm announces its intention to acquire Cobra Biomanufacturing Plc]]> Wed, 16 Dec 2009 00:00:00 GMT <![CDATA[Offer for Cobra Bio-manufacturing Plc]]> Wed, 16 Dec 2009 00:00:00 GMT <![CDATA[Statement re: Announcement by Recipharm]]> Wed, 16 Dec 2009 00:00:00 GMT <![CDATA[Possible Offer]]> Wed, 11 Nov 2009 00:00:00 GMT <![CDATA[Completion of GMP manufacture for Scancell’s SCIB1 Clinical Trial ]]> Mon, 02 Nov 2009 00:00:00 GMT <![CDATA[Result of General Meeting]]> Fri, 16 Oct 2009 00:00:00 GMT <![CDATA[Notice of GM]]> Fri, 25 Sep 2009 00:00:00 GMT <![CDATA[Funding Update]]> Mon, 21 Sep 2009 00:00:00 GMT <![CDATA[Cobra Biomanufacturing successfully passes inspection by UK Regulators]]> Cobra Biomanufacturing successfully passes inspection by UK Regulators

]]> Tue, 01 Sep 2009 00:00:00 GMT <![CDATA[Trading Update]]> Fri, 28 Aug 2009 00:00:00 GMT <![CDATA[Cobra Biomanufacturing wins new Adenovirus service contract]]> Wed, 26 Aug 2009 00:00:00 GMT <![CDATA[Directorate Change]]> Directorate Change]]> Fri, 21 Aug 2009 00:00:00 GMT <![CDATA[Interim Results for the half year ended 31 March 2009]]> ]]> Tue, 30 Jun 2009 00:00:00 GMT <![CDATA[Trading Statement]]> Fri, 26 Jun 2009 00:00:00 GMT <![CDATA[KAHR Medical and Cobra Partner to Develop Trans Signal Converter Protein Production]]> Mon, 11 May 2009 00:00:00 GMT <![CDATA[Termination of Talks]]> Mon, 11 May 2009 00:00:00 GMT <![CDATA[Share Price Movement]]> Tue, 07 Apr 2009 00:00:00 GMT <![CDATA[Successful Vaccination Against Anthrax Supports Cobra's Oral Vaccine Delivery Technology]]> Mon, 06 Apr 2009 00:00:00 GMT <![CDATA[Provision of Annual Report and Accounts]]> Tue, 31 Mar 2009 00:00:00 GMT <![CDATA[Preliminary Results for the year ended 30 September 2008]]> Wed, 25 Mar 2009 00:00:00 GMT <![CDATA[Trading Statement]]> Mon, 23 Mar 2009 00:00:00 GMT <![CDATA[Trading Statement]]> Fri, 13 Mar 2009 00:00:00 GMT <![CDATA[GMP manufacture deal with Scancell Holdings]]> Thu, 22 Jan 2009 00:00:00 GMT <![CDATA[Hawaii Biotech Inc. finishes Phase I West Nile clinical trial]]> Hawaii Biotech Inc. finishes Phase I West Nile clinical trial

]]> Mon, 19 Jan 2009 00:00:00 GMT <![CDATA[Cobrabio and ViroMed extend collaboration and intend to form an R&D and commercial supply joint venture]]> Thu, 24 Jul 2008 00:00:00 GMT <![CDATA[Interim results for the six months ended 31 March 2008]]> ]]> Thu, 26 Jun 2008 00:00:00 GMT <![CDATA[Cobrabio Announces Manufacturing Agreement with ViroMed for VM206RY]]> Mon, 09 Jun 2008 00:00:00 GMT <![CDATA[Result of Extraordinary General Meeting]]> ]]> Fri, 30 May 2008 00:00:00 GMT <![CDATA[Cobra Biomanufacturing Wins “Best Contract Manufacturing Organisation” in ViE Awards ]]> Wed, 21 May 2008 00:00:00 GMT <![CDATA[Trading Update and Fund Raising]]> Wed, 07 May 2008 00:00:00 GMT <![CDATA[Cobra Biomanufacturing Launches New Website]]> Thu, 17 Apr 2008 00:00:00 GMT <![CDATA[Cobra Biomanufacturing Plc reçoit l'accord Crédit d'Impôt Recherche (CIR) du Ministère délégué à l'Enseignement Supérieur et à la Recherche]]> ]]> Thu, 13 Mar 2008 00:00:00 GMT <![CDATA[Cobra Biomanufacturing Plc receives approval for research and development tax credit (Le Crédit d'Impôt Recherche (CIR)) from the French Ministry for Higher Education and Research]]> Thu, 13 Mar 2008 00:00:00 GMT <![CDATA[Cobra enters into manufacturing agreement to produce SARS protein in CHO cells]]> ]]> Mon, 25 Feb 2008 00:00:00 GMT <![CDATA[Cobra Announces Prize for Presentation on its Rapid Mammalian Protein Expression Technology, UCOE]]> Tue, 19 Feb 2008 00:00:00 GMT <![CDATA[Cobra Announces Manufacturing Agreement for TNFerade™]]> ]]> Fri, 25 Jan 2008 00:00:00 GMT <![CDATA[Preliminary Results for the year ended 30 September 2007]]> ]]> Fri, 18 Jan 2008 00:00:00 GMT <![CDATA[Appointment of Chief Operating Officer]]> ]]> Fri, 18 Jan 2008 00:00:00 GMT <![CDATA[Cobra Biomanufacturing to Support Development of the University of Rochester's HIV Vaccine Platform]]> ]]> Thu, 25 Oct 2007 00:00:00 GMT <![CDATA[Cobra Signs Agreement with Advaxis to Manufacture Lovaxin C Vaccine]]> ]]> Mon, 22 Oct 2007 00:00:00 GMT <![CDATA[Year-End Trading Update]]> ]]> Thu, 27 Sep 2007 00:00:00 GMT <![CDATA[AIM Rule 26]]>
]]> Fri, 17 Aug 2007 00:00:00 GMT <![CDATA[Cobra Collaborates On Space Research]]> ]]> Fri, 27 Jul 2007 00:00:00 GMT <![CDATA[Interim results for the six months ended 31 March 2007]]> ]]> Thu, 28 Jun 2007 00:00:00 GMT <![CDATA[Cobra Awarded DTI Grant to Develop Cobra's Oral Vaccine Delivery Platform]]> ]]> Thu, 31 May 2007 00:00:00 GMT <![CDATA[Cobra Biomanufacturing Update on Manufacturing Agreement with GlaxoSmithKline and the International AIDS Vaccine Initiative]]> ]]> Fri, 18 May 2007 00:00:00 GMT <![CDATA[AGM and Trading Update]]> ]]> Thu, 12 Apr 2007 00:00:00 GMT <![CDATA[Cobra joins international consortium to develop oral vaccines]]> ]]> Tue, 06 Mar 2007 00:00:00 GMT <![CDATA[Cobra announces manufacturing agreement with Pharmexa]]> ]]> Thu, 01 Feb 2007 00:00:00 GMT <![CDATA[Cobra appoints General Manager for Oxford Facility]]> ]]> Wed, 31 Jan 2007 00:00:00 GMT <![CDATA[Cobra signs agreement with Cequent to evaluate Cobra's ORT Technology for RNAi Delivery]]> ]]> Thu, 18 Jan 2007 00:00:00 GMT <![CDATA[Preliminary Results for the year ended 30 September 2006]]> ]]> Tue, 09 Jan 2007 00:00:00 GMT <![CDATA[Cobra signs agreement with US Naval Medical Research Center to evaluate Cobra's oral vaccine delivery platform]]> ]]> Mon, 16 Oct 2006 00:00:00 GMT <![CDATA[Cobra Bio-Manufacturing Plc]]> Thu, 12 Oct 2006 00:00:00 GMT <![CDATA[Cobra to support novel gene therapy trials]]> ]]> Tue, 12 Sep 2006 00:00:00 GMT <![CDATA[Cobra Strengthens Management Team]]> Wed, 23 Aug 2006 00:00:00 GMT <![CDATA[Cobra Extends Agreement to Manufacture AA4500 for Auxilium Pharmaceuticals, Inc.]]> ]]> Mon, 17 Jul 2006 00:00:00 GMT <![CDATA[Interim results for the six months ended 31 March 2006]]> ]]> Thu, 29 Jun 2006 00:00:00 GMT <![CDATA[Appointment of Non-Executive Director]]> Thu, 29 Jun 2006 00:00:00 GMT <![CDATA[Cobra Granted Two European Patents]]> Mon, 19 Jun 2006 00:00:00 GMT <![CDATA[Cobra Biomanufacturing Signs Manufacturing Agreement with the International AIDS Vaccine Initiative and GlaxoSmithKline]]> Tue, 02 May 2006 00:00:00 GMT <![CDATA[Cobra develops new genetic engineering tool for inserting genes into bacteria]]> Fri, 07 Apr 2006 00:00:00 GMT <![CDATA[AGM Statement/Trading Update]]> Thu, 06 Apr 2006 00:00:00 GMT <![CDATA[Cobra Biomanufacturing PLC further strengthens business development team with strategic US East Coast appointment]]> ]]> Mon, 03 Apr 2006 00:00:00 GMT <![CDATA[Cobra Signs Contract with Replikun Biotech for Novel Gene Therapy Approach]]> Mon, 30 Jan 2006 00:00:00 GMT <![CDATA[Cobra Biomanufacturing Signs Agreement with Debiopharm to Supply Biopharmaceutical Protein]]> Fri, 20 Jan 2006 00:00:00 GMT <![CDATA[ Preliminary Results for the year ended 30 September 2005]]> Tue, 10 Jan 2006 00:00:00 GMT <![CDATA[ Cobra Biomanufacturing Plc Preliminary Results]]> Wed, 14 Dec 2005 00:00:00 GMT <![CDATA[ Cobra Further Strengthens Management Team]]> Wed, 16 Nov 2005 00:00:00 GMT <![CDATA[ Cobra Biomanufacturing PLC and Advaxis, Inc enter a Strategic Collaboration and Long-Term Vaccine Supply Agreement for Listeria Cancer Vaccines]]> Mon, 07 Nov 2005 00:00:00 GMT <![CDATA[ Year-End Trading Update]]> Mon, 10 Oct 2005 00:00:00 GMT <![CDATA[ Cobra and Auxilium Announce Extension of Agreement to Manufacture AA4500 for Auxilium Pharmaceuticals, Inc.]]> Wed, 10 Aug 2005 00:00:00 GMT <![CDATA[Following Inspection by UK Regulators, Cobra’s Manufacturing Authorisation is extended]]> Thu, 21 Jul 2005 00:00:00 GMT <![CDATA[Interim results for the six months ended 31 March 2005]]> Thu, 30 Jun 2005 00:00:00 GMT <![CDATA[ Cobra Signs Agreement with Introgen Therapeutics for Manufacturing Services]]> Thu, 02 Jun 2005 00:00:00 GMT <![CDATA[Cobra Biomanufacturing and Synco Biopartners Form Alliance to Manufacture Plasmid DNA for Phase III Trials and Commercial Supply]]> Wed, 04 May 2005 00:00:00 GMT <![CDATA[ AGM Statement/Trading Update]]> Fri, 15 Apr 2005 00:00:00 GMT <![CDATA[Pre-clinical Data Supports Potential of Cobra's Proprietary ORT-VAC Oral Bacterial Vaccine]]> Wed, 23 Mar 2005 00:00:00 GMT <![CDATA[ Cobra signs agreement with Hawaii Biotech Inc to manufacture two novel protein vaccines against Dengue fever and West Nile disease for US clinical trials]]> Wed, 02 Mar 2005 00:00:00 GMT <![CDATA[ Cobra signs long term deal with Neovacs SA to supply Phase I clinical trial material for a novel protein active immunization therapy-TNFa Kinoid]]> Fri, 25 Feb 2005 00:00:00 GMT <![CDATA[ New trial of HIV/AIDS vaccine incorporates Cobra technology]]> Fri, 18 Feb 2005 00:00:00 GMT <![CDATA[ US deal takes order book to £5.9m]]> Fri, 11 Feb 2005 00:00:00 GMT <![CDATA[Appointment of Adviser]]> ]]> Thu, 16 Dec 2004 00:00:00 GMT <![CDATA[Cobra increases quality capabilities and further strengthens compliance with the latest EC clinical trials directive - Nick Hill appointed as Director of Quality, Oxford]]> Tue, 30 Nov 2004 00:00:00 GMT <![CDATA[Preliminary Results Announcement Date]]> Mon, 29 Nov 2004 00:00:00 GMT <![CDATA[Trading Update]]> Thu, 07 Oct 2004 00:00:00 GMT <![CDATA[Cobra Biomanufacturing appoints Cathy Smith to strengthen North America Sales]]> ]]> Thu, 30 Sep 2004 00:00:00 GMT <![CDATA[Cobra authorised to manufacture broad range of biopharmaceuticals for European Clinical trials]]> ]]> Mon, 09 Aug 2004 00:00:00 GMT <![CDATA[Cobra Biomanufacturing signs agreement to manufacture Coley’s Toxin]]>
]]> Mon, 28 Jun 2004 00:00:00 GMT <![CDATA[Interim results for the six months ended 31 March 2004]]> ]]> Wed, 02 Jun 2004 00:00:00 GMT <![CDATA[Cobra Licenses DNA Manufacturing Technology to AstraZeneca]]> ]]> Fri, 30 Apr 2004 00:00:00 GMT <![CDATA[Cobra Awarded US Patent for Manufacture of Biopharmaceuticals]]> ]]> Mon, 19 Apr 2004 00:00:00 GMT <![CDATA[Cobra Signs Agreement to Manufacture Reolysin® for Oncolytics Biotech Inc]]> ]]> Mon, 05 Apr 2004 00:00:00 GMT <![CDATA[Cobra Signs Agreement to Manufacture Avidex’ First Monoclonal T Cell Receptors]]> ]]> Tue, 09 Mar 2004 00:00:00 GMT <![CDATA[Annual General Meeting]]> ]]> Thu, 26 Feb 2004 00:00:00 GMT <![CDATA[Trading Update]]> ]]> Mon, 09 Feb 2004 00:00:00 GMT <![CDATA[Cobra Awarded Key US Patent for Oral Vaccine]]>
]]> Mon, 19 Jan 2004 00:00:00 GMT <![CDATA[Board Appointment]]> ]]> Tue, 02 Dec 2003 00:00:00 GMT <![CDATA[Preliminary Results for the year ended 30 September 2003]]> ]]> Tue, 02 Dec 2003 00:00:00 GMT <![CDATA[Novel Cancer Vaccine to be Manufactured from Live Bacterium]]> ]]> Mon, 04 Aug 2003 00:00:00 GMT <![CDATA[Placing and Open Offer of 6,500,000 new Ordinary Shares of 10p each at 80p per share.]]> ]]> Thu, 29 May 2003 00:00:00 GMT <![CDATA[Interim Results for the six months ended 31 March 2003]]> ]]> Thu, 29 May 2003 00:00:00 GMT <![CDATA[Cobra Biomanufacturing Wins Agreement to Supply Innovative Sheep Adenovirus for Prostate Cancer]]> ]]> Wed, 11 Dec 2002 00:00:00 GMT <![CDATA[Maiden Preliminary Results for the year ended 30 September 2002]]> ]]> Wed, 11 Dec 2002 00:00:00 GMT <![CDATA[Cobra Biomanufacturing Opens US Sales Office and Further Strengthens Business Development Team with Strategic US Appointment]]> ]]> Thu, 28 Nov 2002 00:00:00 GMT <![CDATA[Cobra Biomanufacturing Wins DNA Vaccine Supply Agreement with the South African AIDS Vaccine Initiative]]> ]]> Mon, 18 Nov 2002 00:00:00 GMT <![CDATA[Double First from FDA for Evolutec and Cobra]]> ]]> Wed, 06 Nov 2002 00:00:00 GMT <![CDATA[Cobra Biomanufacturing plc publishes Full Prospectus for AIM admission]]> ]]> Sun, 09 Jun 2002 00:00:00 GMT <![CDATA[Cobra Therapeutics Collects Award for Innovation in Biopharmaceuticals Manufacture]]> ]]> Tue, 17 Jul 2001 00:00:00 GMT